Feb 27 |
Alcon (ALC) Faces Rising Expenses, Tough Competitive Scenario
|
Feb 22 |
Wall Street's Insights Into Key Metrics Ahead of Alcon (ALC) Q4 Earnings
|
Feb 1 |
Alcon Canada Launches TOTAL30 Multifocal Contact Lenses for Reusable Lens Patients with Presbyopia
|
Jan 23 |
Buy This Ophthalmology Stock But Sell This One, Says Bernstein Analyst: 'Innovation Is Key'
|
Jan 19 |
Is Alcon Inc. (VTX:ALC) Worth CHF67.1 Based On Its Intrinsic Value?
|
Jan 10 |
Biggest stock movers today: Virgin Galactic, Amarin, Alcon, Intuitive Surgical, and more
|
Jan 10 |
Good News For Dry Eye Disease Patients: Eye Care Focused Alcon's Treatment Shows Encouraging Benefit In Late-Stage Trials
|
Jan 9 |
Alcon reports positive Phase 3 results for dry eye disease drug
|
Jan 9 |
Alcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry Eye
|
Jan 5 |
Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements
|